U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. How Drugs are Developed and Approved
  5. Over-the-Counter OTC | Nonprescription Drugs
  6. Status of OTC Rulemakings
  7. Rulemaking History for OTC Ophthalmic Drug Products
  1. Status of OTC Rulemakings

Rulemaking History for OTC Ophthalmic Drug Products

Final Monograph (21 CFR part 349):
Ophthalmic Drug Products for Over-the-Counter Human Use
 

OTC Ophthalmic Drug Products found on this page:

Ophthalmic Drug Products: Original Active Ingredients and Labeling

Advance Notice Of Proposed RulemakingDateFR Citation
 Advance Notice of Proposed Rulemaking 5/6/198045FR30002
      Correction7/22/198045FR48920
Proposed RuleDateFR Citation
 Tentative Final Monograph6/28/1983 48FR29788
     Correction7/19/1983 48FR32837
     Reopening of Administrative Record: Yellow mercuric oxide (anti-infective) excluded from
     final monograph
 3/4/198853FR6997 
   
Final RuleDateFR Citation
 Final Monograph3/4/1988 53FR7076 
     Correction4/21/198853FR13217
     Technical Amendment: Revises "hydroxypropyl methylcellulose" to "hypromellose"6/3/200368FR32981
     Technical Amendment: Clarifies Labeling of Active/Inactive Ingredients2/19/200368FR7919

Ophthalmic Drug Products: Emergency First Aid Eyewashes

Advance Notice Of Proposed RulemakingDateFR Citation
 Request or Data12/5/198954FR50240
Proposed RuleDateFR Citation
 Proposed Rule2/19/200368FR7951
Final RuleDateFR Citation
   

Ophthalmic Drug Products: Contact Lens Solution

Advance Notice Of Proposed RulemakingDateFR Citation
Notice: Reclassifies contact lens solution from OTC drug to device3/6/197944FR12270

Ophthalmic Drug Products: Vasoconstrictor Warning

Proposed Amendment of Final MonographDateFR Citation
Proposed Amendment of Final Monograph2/23/199863FR8888
Amendment of Final MonographDateFR Citation
Amendment of Final Monograph6/21/200065FR38426

Back to Top

Back to Top